Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Tablet
Product Images NDC 71335-2070

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 71335-2070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Amphetanine 01)

Chemical structure diagram showing the molecular formula of the active ingredient dextroamphetamine, as part of the combined composition for an oral tablet formulation containing dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate.*

FDA Label Image

Label (Lbl713352070)

Label for Amphetamine Salt Combo (CII) 30 mg Tablet packaged by Bryant Ranch Prepack in Burbank, CA. The label compares this product to Adderall 30 mg Tablet by Sandoz Inc. It includes storage instructions and warnings to keep out of reach of children, with a package count of 60 tablets and NDC 71335-2070.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.